Overview
Distal hereditary motor neuropathy type 7 (dHMN7), also known as HMN7 or distal spinal muscular atrophy type 7, is a rare inherited neuromuscular disorder characterized by progressive weakness and wasting (atrophy) of muscles in the distal extremities, with a distinctive involvement of the vocal cords. The disease is caused by mutations in the SLC5A7 gene (encoding the high-affinity choline transporter) or, in some families, has been linked to chromosome 2q14. It primarily affects the lower motor neurons in the spinal cord, leading to progressive distal muscle weakness predominantly in the hands and feet, along with vocal cord paralysis that can cause breathing difficulties and a hoarse or weak voice. Unlike many other forms of hereditary motor neuropathy, the vocal cord involvement is a hallmark feature that distinguishes dHMN7 from related conditions. The disease typically presents in young adulthood, though the age of onset can vary. Early symptoms often include difficulty with fine motor tasks in the hands, foot drop, and voice changes due to vocal cord paresis. Over time, muscle weakness may progress proximally but tends to remain most severe in the distal limbs. Sensory function is generally preserved, which distinguishes this condition from hereditary motor and sensory neuropathies (Charcot-Marie-Tooth disease). Electromyography (EMG) and nerve conduction studies typically show evidence of chronic denervation with preserved sensory nerve conduction. There is currently no cure or disease-modifying treatment for dHMN7. Management is supportive and multidisciplinary, focusing on physical therapy and occupational therapy to maintain mobility and function, orthotic devices for foot drop, and speech therapy or surgical interventions (such as vocal cord medialization) for vocal cord paralysis. Respiratory monitoring may be necessary in cases where vocal cord dysfunction compromises the airway. Genetic counseling is recommended for affected individuals and their families.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Distal hereditary motor neuropathy type 7.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Distal hereditary motor neuropathy type 7 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Distal hereditary motor neuropathy type 7.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Distal hereditary motor neuropathy type 7.
Community
No community posts yet. Be the first to share your experience with Distal hereditary motor neuropathy type 7.
Start the conversation →Latest news about Distal hereditary motor neuropathy type 7
No recent news articles for Distal hereditary motor neuropathy type 7.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Distal hereditary motor neuropathy type 7
What is Distal hereditary motor neuropathy type 7?
Distal hereditary motor neuropathy type 7 (dHMN7), also known as HMN7 or distal spinal muscular atrophy type 7, is a rare inherited neuromuscular disorder characterized by progressive weakness and wasting (atrophy) of muscles in the distal extremities, with a distinctive involvement of the vocal cords. The disease is caused by mutations in the SLC5A7 gene (encoding the high-affinity choline transporter) or, in some families, has been linked to chromosome 2q14. It primarily affects the lower motor neurons in the spinal cord, leading to progressive distal muscle weakness predominantly in the han
How is Distal hereditary motor neuropathy type 7 inherited?
Distal hereditary motor neuropathy type 7 follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.